Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology

Area of Science:

• Hematology
• Oncology
• Clinical Practice Guidelines

Background:

• The treatment options for multiple myeloma (MM) are expanding rapidly.
• Individualized patient management is crucial in MM care.
• Existing guidelines require updates to reflect new therapeutic advancements.

Purpose of the Study:

• To outline the National Comprehensive Cancer Network (NCCN) Guidelines recommendations for newly diagnosed multiple myeloma (NDMM).
• To provide a framework for clinical decision-making in NDMM.
• To summarize current evidence-based strategies for NDMM management.

Main Methods:

• Review of the latest NCCN Guidelines for Multiple Myeloma.
• Synthesis of recommendations specific to the diagnosis and treatment of NDMM.
• Focus on evidence-based approaches for initial patient management.

Main Results:

• The NCCN Guidelines provide a structured approach to NDMM diagnosis and workup.
• Key treatment recommendations for NDMM are detailed.
• Guidance on follow-up strategies for NDMM patients is presented.

Conclusions:

• NCCN Guidelines offer essential recommendations for the management of newly diagnosed multiple myeloma.
• These guidelines support tailored treatment strategies based on individual patient factors.
• Adherence to NCCN Guidelines promotes optimal care for NDMM patients.